Targeting mTOR signaling by polyphenols: A new therapeutic target for ageing

Ageing Res Rev. 2016 Nov:31:55-66. doi: 10.1016/j.arr.2016.07.004. Epub 2016 Jul 21.

Abstract

Current ageing research is aimed not only at the promotion of longevity, but also at improving ‎health span‎ through the‎ discovery and development‎ of new therapeutic strategies‎‏‎ by investigating ‎molecular and ‎cellular ‎pathways involved in cellular senescence.‎ Understanding the mechanism of action ‎of ‎polyphenolic compounds targeting mTOR (mechanistic target of rapamycin) and related pathways opens up new directions ‎‎to revolutionize ways to slow down the ‎onset and development of age-dependent degeneration. Herein, we will ‎discuss the mechanisms by which polyphenols can delay the‎ molecular ‎pathogenesis of ageing via manipulation or more specifically inhibition of mTOR-signaling pathways. We will also discuss the implications of polyphenols in targeting mTOR and its related ‎pathways‎‎ on ‎health life span extension and longevity.‎.

Keywords: Ageing; Flavonoid; Polyphenol; mTOR.

Publication types

  • Review

MeSH terms

  • Aging / drug effects*
  • Aging / metabolism
  • Animals
  • Cellular Senescence
  • Humans
  • Longevity / physiology
  • Polyphenols / pharmacology*
  • Signal Transduction / drug effects
  • Sirolimus / pharmacology*
  • TOR Serine-Threonine Kinases / drug effects
  • TOR Serine-Threonine Kinases / metabolism*

Substances

  • Polyphenols
  • MTOR protein, human
  • TOR Serine-Threonine Kinases
  • Sirolimus